How I do it: Percutaneous radiofrequency ablation (RFA)

Igor Sorokin, Murthy R Chamarthy, Jeffrey A Cadeddu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Percutaneous radiofrequency ablation has seen increased utilization secondary to the rising incidence of renal cell carcinoma. This has been shown to be an effective and durable treatment especially in the elderly comorbid patient. In this article, we describe our technique and factors related to successful outcomes.

Original languageEnglish (US)
Pages (from-to)8679-8683
Number of pages5
JournalCanadian Journal of Urology
Volume24
Issue number1
StatePublished - 2017

Fingerprint

Renal Cell Carcinoma
Incidence
Therapeutics

Keywords

  • Kidney cancer
  • Percutaneous radiofrequency ablation
  • Renal cell carcinoma
  • Renal mass
  • RFA
  • Thermal ablation

ASJC Scopus subject areas

  • Medicine(all)
  • Urology

Cite this

How I do it : Percutaneous radiofrequency ablation (RFA). / Sorokin, Igor; Chamarthy, Murthy R; Cadeddu, Jeffrey A.

In: Canadian Journal of Urology, Vol. 24, No. 1, 2017, p. 8679-8683.

Research output: Contribution to journalArticle

Sorokin, I, Chamarthy, MR & Cadeddu, JA 2017, 'How I do it: Percutaneous radiofrequency ablation (RFA)', Canadian Journal of Urology, vol. 24, no. 1, pp. 8679-8683.
Sorokin, Igor ; Chamarthy, Murthy R ; Cadeddu, Jeffrey A. / How I do it : Percutaneous radiofrequency ablation (RFA). In: Canadian Journal of Urology. 2017 ; Vol. 24, No. 1. pp. 8679-8683.
@article{f9bc09c7c07044a796bcace5f63b76d7,
title = "How I do it: Percutaneous radiofrequency ablation (RFA)",
abstract = "Percutaneous radiofrequency ablation has seen increased utilization secondary to the rising incidence of renal cell carcinoma. This has been shown to be an effective and durable treatment especially in the elderly comorbid patient. In this article, we describe our technique and factors related to successful outcomes.",
keywords = "Kidney cancer, Percutaneous radiofrequency ablation, Renal cell carcinoma, Renal mass, RFA, Thermal ablation",
author = "Igor Sorokin and Chamarthy, {Murthy R} and Cadeddu, {Jeffrey A}",
year = "2017",
language = "English (US)",
volume = "24",
pages = "8679--8683",
journal = "The Canadian journal of urology",
issn = "1195-9479",
publisher = "Canadian Journal of Urology",
number = "1",

}

TY - JOUR

T1 - How I do it

T2 - Percutaneous radiofrequency ablation (RFA)

AU - Sorokin, Igor

AU - Chamarthy, Murthy R

AU - Cadeddu, Jeffrey A

PY - 2017

Y1 - 2017

N2 - Percutaneous radiofrequency ablation has seen increased utilization secondary to the rising incidence of renal cell carcinoma. This has been shown to be an effective and durable treatment especially in the elderly comorbid patient. In this article, we describe our technique and factors related to successful outcomes.

AB - Percutaneous radiofrequency ablation has seen increased utilization secondary to the rising incidence of renal cell carcinoma. This has been shown to be an effective and durable treatment especially in the elderly comorbid patient. In this article, we describe our technique and factors related to successful outcomes.

KW - Kidney cancer

KW - Percutaneous radiofrequency ablation

KW - Renal cell carcinoma

KW - Renal mass

KW - RFA

KW - Thermal ablation

UR - http://www.scopus.com/inward/record.url?scp=85014498379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014498379&partnerID=8YFLogxK

M3 - Article

C2 - 28263138

AN - SCOPUS:85014498379

VL - 24

SP - 8679

EP - 8683

JO - The Canadian journal of urology

JF - The Canadian journal of urology

SN - 1195-9479

IS - 1

ER -